No Data
No Data
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
EDAP TMS Shares Are Trading Higher After the Company Announced the FARP Study Achieved Its Primary Endpoint.
EDAP TMS Final Results Of FARP Study Achieves Primary Endpoint, Confirms Non-Inferiority Of Focal Ablation Vs. Radical Prostatectomy At 36-Month Follow-Up
EDAP TMS to Launch New Focal One I Robotic HIFU System
EDAP Announces Significant Presence of Focal One at the Upcoming 120th American Urological Association (AUA) Annual Meeting
New Analyst Forecast: $EDAP Given 'Hold' Rating